CIMT-Partners.png
 

Partners

CIMT actively engages in international collaborations to advance the field of cancer immunotherapy through scientific exchange, joint initiatives, and strategic partnerships.

CIMT is a member society of the Federation of Clinical Immunology Societies (FOCIS) and a founding member of the European Network for Cancer Immunotherapy (ENCI)—a joint initiative of leading European societies dedicated to the advancement of cancer immunotherapy. ENCI functions as a collaborative information and networking platform that harmonizes activities across the European cancer immunotherapy community. Through cross-border cooperation, scientific meetings, information dissemination, and engagement with political decision-makers, ENCI seeks to accelerate the development and implementation of cancer immunotherapy throughout Europe.

CIMT also collaborates closely with major international organizations, including the Cancer Research Institute (CRI), particularly through the International Cancer Immunotherapy Conference (CICON).

To support the next generation of scientists, CIMT has partnered with the Young European Federation of Immunological Societies (yEFIS), fostering connections among early-career researchers in immunology across Europe.

Additionally, CIMT maintains an active affiliation with the journal Human Vaccines & Immunotherapeutics.

Empfohlen
Since 2008, CIMT and the Cancer Immunotherapy Consortium (CIC) of the Cancer Research Institute (CRI) have joined forces in different projects. Our CIMT Immunoguiding Program (CIP) has partnered with CIC to set new standards and harmonize protocols
In 2011, CIMT was granted society membership of the Federation of Clinical Immunology Societies (FOCIS). CIMT and all CIMT members can take full advantage of being a FOCIS Members Society including professional development resources and discounted r
ENCI.jpg
yefis.png
HV&I logo_grau.jpg